Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-9.51%
operating margin TTM
-20.46%
revenue TTM
195.26 Million
revenue per share TTM
3.35$
valuation ratios | |
|---|---|
| pe ratio | -13.48 |
| peg ratio | 0.75 |
| price to book ratio | 0.47 |
| price to sales ratio | 1.29 |
| enterprise value multiple | -10.62 |
| price fair value | 0.47 |
profitability ratios | |
|---|---|
| gross profit margin | 92.41% |
| operating profit margin | -20.46% |
| pretax profit margin | -11.53% |
| net profit margin | -9.51% |
| return on assets | -2.88% |
| return on equity | -3.49% |
| return on capital employed | -7.31% |
liquidity ratio | |
|---|---|
| current ratio | 4.39 |
| quick ratio | 4.37 |
| cash ratio | 1.02 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 41.77 |
| operating cycle | 128.26 |
| days of payables outstanding | 84.64 |
| cash conversion cycle | 43.61 |
| receivables turnover | 4.22 |
| payables turnover | 4.31 |
| inventory turnover | 8.74 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.02 |
| debt equity ratio | 0.02 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.02 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -1.27 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.28 |
| cash per share | 6.44 |
| operating cash flow per share | -0.27 |
| free cash flow operating cash flow ratio | 1.03 |
| cash flow coverage ratios | -1.27 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -32.16 |
Frequently Asked Questions
When was the last time Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) reported earnings?
Vanda Pharmaceuticals Inc. (VNDA) published its most recent earnings results on 07-11-2024.
What is Vanda Pharmaceuticals Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)'s trailing twelve months ROE is -3.49%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Vanda Pharmaceuticals Inc. (VNDA) currently has a ROA of -2.88%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did VNDA's net profit margin stand at?
VNDA reported a profit margin of -9.51% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is VNDA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.39 in the most recent quarter. The quick ratio stood at 4.37, with a Debt/Eq ratio of 0.02.